Miriam Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Miriam Kidron is Chief Scientific Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 763,666 shares of ORMP, which is worth approximately $1.77 Million. The most recent transaction as insider was on Jan 04, 2024, when has been sold 295,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 764K
0% 3M change
63.12% 12M change
Total Value Held $1.77 Million

Miriam Kidron Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2024
BUY
Grant, award, or other acquisition
-
295,500 Added 27.9%
763,666 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
53,500 Added 10.26%
468,166 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
213,000 Added 33.94%
414,666 Common Stock
Mar 14 2023
SELL
Open market or private sale
$200,999 $2.01 p/Share
100,000 Reduced 33.15%
201,666 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
118,000 Added 28.12%
301,666 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
42,000 Added 18.61%
183,666 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
-
66,666 Added 32.0%
141,666 Common Stock
MK

Miriam Kidron

Chief Scientific Officer
Jerusalem, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP